XML 56 R45.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Reporting (Details)
$ in Thousands
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Jun. 30, 2024
USD ($)
Mar. 31, 2024
USD ($)
Jun. 30, 2025
USD ($)
segment
Jun. 30, 2024
USD ($)
Dec. 31, 2024
USD ($)
Segment Reporting              
Number of operating segments | segment         1    
Grant Income         $ 12,192 $ 12,223  
Less:              
Clinical programs         15,051 14,335  
R&D Personnel costs         4,973 5,221  
Preclinical programs         225 525  
Manufacturing         1,150 1,412  
Other research and development expenses         227 124  
General and administrative expenses (excluding equity-based compensation)         4,920 4,845  
Equity-based compensation $ 621   $ 1,147   1,207 2,318  
Other segment items         (347) (365)  
Net loss $ (6,734) $ (8,480) $ (7,041) $ (9,151) $ (15,214) $ (16,192) $ (33,971)
Other segment reporting description         Other segment items include, Other income, net, Interest expense and Loss on currency translation from liquidation of subsidiary